DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas - Wikidata - awgldk - TriplyDB

DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas

DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas

http://www.wikidata.org/entity/Q34582022

about

Can Dynamic Contrast-Enhanced MRI (DCE-MRI) and Diffusion-Weighted MRI (DW-MRI) Evaluate Inflammation Disease: A Preliminary Study of Crohn's Disease Evaluation of neovascularization patterns in an orthotopic rat glioma model with dynamic contrast-enhanced MRI.Early growth response-1 in the pathogenesis of cardiovascular disease.Efficacy of recombinant adenovirus expressing a fusion gene from GM-CSF and Epstein-Barr virus LMP2A in a mouse tumor model.Aberrant glioblastoma neovascularization patterns and their correlation with DCE-MRI-derived parameters following temozolomide and bevacizumab treatment.

P2860

Q37206657-70344363-AE54-4A04-B120-1237440446B3 Q38783784-469D6CBE-D488-4D4B-9ED4-C2022B3D81D9 Q38850831-68AF7613-1664-4B56-AD0B-9A085811C447 Q40047749-8277BC42-5EC3-4A1E-B50D-72939641BDF3 Q42638789-A9BE8A85-A309-40CC-BB9E-A1B34580E06A

P2860

DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas

http://www.wikidata.org/entity/Q34582022

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

DCE-MRI assessment of the effe ...... with nasopharyngeal carcinomas

@ast

DCE-MRI assessment of the effe ...... with nasopharyngeal carcinomas

@en

DCE-MRI assessment of the effe ...... with nasopharyngeal carcinomas

@nl

type

label

DCE-MRI assessment of the effe ...... with nasopharyngeal carcinomas

@ast

DCE-MRI assessment of the effe ...... with nasopharyngeal carcinomas

@en

DCE-MRI assessment of the effe ...... with nasopharyngeal carcinomas

@nl

prefLabel

DCE-MRI assessment of the effe ...... with nasopharyngeal carcinomas

@ast

DCE-MRI assessment of the effe ...... with nasopharyngeal carcinomas

@en

DCE-MRI assessment of the effe ...... with nasopharyngeal carcinomas

@nl

P1433

Q34582022-B03C766F-1E99-44B4-91D3-E074DE86CEBE

P1476

Q34582022-BD510C16-1DBB-4BC1-B988-495EBFABD292

P2093

Q34582022-07FD929C-FA91-453C-9B95-282837E453B8

Q34582022-6800B5F0-75A1-413E-8F9B-BE69EE15AC18

Q34582022-79A03AB5-D2EE-4D9E-8FCA-38EC1E135EB9

Q34582022-8B6DA4A9-9596-4E3D-9975-09B0E64B71B4

Q34582022-9F5A77D4-B011-48B6-AA89-4A5EAC6F9BE9

Q34582022-C96FCED8-6EFF-44B4-9741-CE721E452D78

Q34582022-EB7D46F7-7208-4579-9EFE-9C1F43D204D7

Q34582022-EBC86831-2BE3-4627-B535-491ADCDA2168

Q34582022-FE329AAD-C16B-4C5E-8459-03455FD158BD

P2860

Q34582022-0AF56B96-16FA-4F5B-89F2-6110F7C98636

Q34582022-2DDC205A-9D3F-4A78-8136-C68F7AC2CDAC

Q34582022-3361673F-0381-4FFF-808A-8C5E54E8ED1C

Q34582022-3B71594E-A499-46EE-B684-A561235D915D

Q34582022-436797EE-21A0-4DE9-BA18-C6948393ED31

Q34582022-47DAE19F-A143-48EA-B84A-12C333D626BE

Q34582022-5E9FB88B-F617-485A-BEED-1035719BAF56

Q34582022-6BFDE016-D261-4DDA-B4F1-5A37079DE6FC

Q34582022-7805998E-CA47-4D92-8C81-276B5DB1EE91

Q34582022-816FBF29-EEF6-41C6-A898-4B3959C8FFD5

P2888

Q34582022-825C58E2-450F-4A5A-B102-284FD5B9996E

P304

Q34582022-A2400373-DE1C-40FA-8BC2-A61D282E9D59

P31

Q34582022-92F34ED4-C791-408B-8F6A-0D9E5803EB0C

P356

Q34582022-ACD187BE-0EF4-4A51-949D-2D736809D522

P407

Q34582022-C0E8F353-933E-452C-AFBD-68B73A0F0D72

P478

Q34582022-B7229047-5C00-4BBD-A06B-C0304937A1A8

P577

Q34582022-67481DCF-224D-4FCA-AC73-5875BD7F2FAB

P5875

Q34582022-65009529-0A1F-4879-AB75-0275F0581C67

P6179

Q34582022-7AEA3A12-A5FC-4CA8-A2EE-2976E8921619

P698

Q34582022-D0CA8F5A-7B32-4CEB-B7F3-81B1FE84A81B

P921

Q34582022-96156C9A-EA47-4B6E-9544-CE269D40A6BF

P932

Q34582022-7EC056D1-E1C8-4793-9345-44965E064F54

P356

1471-2407-14-835

P1433

P1476

DCE-MRI assessment of the effe ...... with nasopharyngeal carcinomas

@en

P2093

Bob-Lei Hou

http://www.w3.org/2001/XMLSchema#string

Gao-Feng Zhou

http://www.w3.org/2001/XMLSchema#string

Li-Fang Yang

http://www.w3.org/2001/XMLSchema#string

Lun-Quan Sun

http://www.w3.org/2001/XMLSchema#string

Wei-Hua Liao

http://www.w3.org/2001/XMLSchema#string

Wu-Zhong Jiang

http://www.w3.org/2001/XMLSchema#string

Xiao-Yi Wang

http://www.w3.org/2001/XMLSchema#string

Xiao-Yu Liu

http://www.w3.org/2001/XMLSchema#string

Ya Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma.

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors.

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy.

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents.

Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging.

Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

P2888

1471-2407-14-835

P304

835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-835

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268788075

http://www.w3.org/2001/XMLSchema#string

P6179

1024606096

http://www.w3.org/2001/XMLSchema#string

P698

25407966

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

4246516

http://www.w3.org/2001/XMLSchema#string